Study of Penn patients with decade-long leukemia remissions after CAR T cell therapy revealed new details about persistence of personalized ‘Living Drug’ cells
| | | | |

Study of Penn patients with decade-long leukemia remissions after CAR T cell therapy revealed new details about persistence of personalized ‘Living Drug’ cells

On Feb. 2, 2022, a new analysis of the first two patients treated in a clinical trial with…

Resilience collaborated with Children’s Hospital of Philadelphia to develop next-gen biomanufacturing technologies
| | | | | | | |

Resilience collaborated with Children’s Hospital of Philadelphia to develop next-gen biomanufacturing technologies

On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…